openPR Logo
Press release

Von Hippel-Lindau Disease Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examine DelveInsight | Merck, Novartis, Peloton Therapeutics

05-24-2024 08:08 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Von Hippel-Lindau Disease Market to Witness Upsurge in Growth

DelveInsight's "Von Hippel-Lindau Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Von Hippel-Lindau Disease, historical and forecasted epidemiology as well as the Von Hippel-Lindau Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Von Hippel-Lindau Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Von Hippel-Lindau Disease Market Forecast
https://www.delveinsight.com/sample-request/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Von Hippel-Lindau Disease Market Report:
• The Von Hippel-Lindau Disease market size was valued approximately USD 300 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In 2023, the United States had the largest market size for Von Hippel-Lindau disease among the 7MM, amounting to nearly USD 200 million.
• Among the 7MM countries, the United States had the highest number of total prevalent cases of Von Hippel-Lindau disease, with approximately 9,500 cases in 2023.
• In the EU4 and the UK, Germany had the highest number of diagnosed cases of Von Hippel-Lindau disease, while Spain had the lowest in 2023.
• In 2023, retinal hemangioblastomas accounted for approximately 21% of the most prevalent clinical manifestation-specific cases of Von Hippel-Lindau disease in the United States.
• Currently, the dominant drug in the market for Von Hippel-Lindau disease is WELIREG (belzutifan).
• Key Von Hippel-Lindau Disease Companies: Merck, Novartis, Peloton Therapeutics, and others
• Key Von Hippel-Lindau Disease Therapies: WELIREG (belzutifan), DFF332, Belzutifan, and others
• The Von Hippel-Lindau Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Von Hippel-Lindau Disease pipeline products will significantly revolutionize the Von Hippel-Lindau Disease market dynamics.

Von Hippel-Lindau Disease Overview

Get a Free sample for the Von Hippel-Lindau Disease Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Von Hippel-Lindau Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Von Hippel-Lindau Disease Epidemiology Segmentation:
The Von Hippel-Lindau Disease market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Von Hippel-Lindau Disease
• Prevalent Cases of Von Hippel-Lindau Disease by severity
• Gender-specific Prevalence of Von Hippel-Lindau Disease
• Diagnosed Cases of Episodic and Chronic Von Hippel-Lindau Disease

Download the report to understand which factors are driving Von Hippel-Lindau Disease epidemiology trends @ Von Hippel-Lindau Disease Epidemiology Forecast
https://www.delveinsight.com/sample-request/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

KOL Views:
United States
"Von Hippel-Lindau disease involves an E3 ubiquitin ligase that regulates the hypoxia-inducible factor (HIF), a transcription factor. Traditionally, transcription factors have been deemed undruggable due to their small, tightly folded structure lacking binding sites for small molecules. However, belzutifan addresses this challenge by interacting with the PAS-B domain in HIF2α, preventing it from heterodimerizing with HIF-1 beta, and thereby inhibiting the transcription of angiogenic factors."

Von Hippel-Lindau Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Von Hippel-Lindau Disease market or expected to get launched during the study period. The analysis covers Von Hippel-Lindau Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Von Hippel-Lindau Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Von Hippel-Lindau Disease Therapies and Key Companies
• WELIREG (belzutifan): Merck
• DFF332: Novartis
• Belzutifan: Peloton Therapeutics

Discover more about therapies set to grab major Von Hippel-Lindau Disease market share @ Von Hippel-Lindau Disease Treatment Landscape
https://www.delveinsight.com/sample-request/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Scope of the Von Hippel-Lindau Disease Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Von Hippel-Lindau Disease Companies: Merck, Novartis, Peloton Therapeutics, and others
• Key Von Hippel-Lindau Disease Therapies: WELIREG (belzutifan), DFF332, Belzutifan, and others
• Von Hippel-Lindau Disease Therapeutic Assessment: Von Hippel-Lindau Disease current marketed and Von Hippel-Lindau Disease emerging therapies
• Von Hippel-Lindau Disease Market Dynamics: Von Hippel-Lindau Disease market drivers and Von Hippel-Lindau Disease market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Von Hippel-Lindau Disease Unmet Needs, KOL's views, Analyst's views, Von Hippel-Lindau Disease Market Access and Reimbursement

To know more about Von Hippel-Lindau Disease companies working in the treatment market, visit @ Von Hippel-Lindau Disease Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/von-hippel-lindau-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Von Hippel-Lindau Disease Market Report Introduction
2. Executive Summary for Von Hippel-Lindau Disease
3. SWOT analysis of Von Hippel-Lindau Disease
4. Von Hippel-Lindau Disease Patient Share (%) Overview at a Glance
5. Von Hippel-Lindau Disease Market Overview at a Glance
6. Von Hippel-Lindau Disease Disease Background and Overview
7. Von Hippel-Lindau Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Von Hippel-Lindau Disease
9. Von Hippel-Lindau Disease Current Treatment and Medical Practices
10. Von Hippel-Lindau Disease Unmet Needs
11. Von Hippel-Lindau Disease Emerging Therapies
12. Von Hippel-Lindau Disease Market Outlook
13. Country-Wise Von Hippel-Lindau Disease Market Analysis (2020-2034)
14. Von Hippel-Lindau Disease Market Access and Reimbursement of Therapies
15. Von Hippel-Lindau Disease Market Drivers
16. Von Hippel-Lindau Disease Market Barriers
17. Von Hippel-Lindau Disease Appendix
18. Von Hippel-Lindau Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:

Von Hippel-Lindau Disease Pipeline https://www.delveinsight.com/report-store/von-hippel-lindau-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Von Hippel-Lindau Disease Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Von Hippel-Lindau Disease market. A detailed picture of the Von Hippel-Lindau Disease pipeline landscape is provided, which includes the disease overview and Von Hippel-Lindau Disease treatment guidelines.

Von Hippel-Lindau Disease Epidemiology https://www.delveinsight.com/report-store/von-hippel-lindau-disease-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Von Hippel-Lindau Disease Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Von Hippel-Lindau Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market
DelveInsight's "Crows Feet Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Crows Feet, historical and forecasted epidemiology as well as the Crows Feet market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Dermatitis Seborrheic Market https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market
DelveInsight's "Seborrhoeic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Seborrhoeic Dermatitis, historical and forecasted epidemiology as well as the Seborrhoeic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Gastro Intestinal Bleeding Market https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market
DelveInsight's "Gastro Intestinal Bleeding Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastro Intestinal Bleeding, historical and forecasted epidemiology as well as the Gastro Intestinal Bleeding market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Listeriosis Market
https://www.delveinsight.com/report-store/listeriosis-market
DelveInsight's comprehensive report titled "Listeriosis Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.

Point Of Care Glucose Testing Market https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market
DelveInsight's 'Point of Care Glucose Testing Market Insight, Competitive Landscape and Market Forecast, 2030' report delivers an in-depth understanding of Point of Care Glucose Testing and the historical and forecasted Point of Care Glucose Testing market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Substance Drug Abuse Market https://www.delveinsight.com/report-store/substance-drug-abuse-market
DelveInsight's "Substance (Drug) Abuse Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance (Drug) Abuse, historical and forecasted epidemiology as well as the Substance (Drug) Abuse market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +14699457679
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Von Hippel-Lindau Disease Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examine DelveInsight | Merck, Novartis, Peloton Therapeutics here

News-ID: 3512184 • Views:

More Releases from DelveInsight Business Research

Tonic clonic Seizure Market to Experience Notable Growth in Forecast Span by 2032, DelveInsight Predicts
Tonic clonic Seizure Market to Experience Notable Growth in Forecast Span by 203 …
DelveInsight's "Tonic clonic Seizure Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Tonic clonic Seizure, historical and forecasted epidemiology as well as the Tonic clonic Seizure market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Tonic clonic Seizure, offering comprehensive insights into the Tonic clonic Seizure revenue trends,
Panic Disorder Market Insights Highlight Expanding Outlook Till 2032, DelveInsight Evaluates
Panic Disorder Market Insights Highlight Expanding Outlook Till 2032, DelveInsig …
DelveInsight's "Panic Disorder Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Panic Disorder, historical and forecasted epidemiology as well as the Panic Disorder market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Panic Disorder, offering comprehensive insights into the Panic Disorder revenue trends, prevalence, and treatment landscape. The
Chronic Pain Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes
Chronic Pain Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight …
DelveInsight's "Chronic Pain Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Chronic Pain, historical and forecasted epidemiology as well as the Chronic Pain market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Chronic Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Pain Market Forecast https://www.delveinsight.com/sample-request/chronic-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Chemotherapy-induced Thrombocytopenia Market Positioned for Accelerated Development Through 2032, DelveInsight Finds
Chemotherapy-induced Thrombocytopenia Market Positioned for Accelerated Developm …
DelveInsight's "Chemotherapy-induced Thrombocytopenia Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Chemotherapy-induced Thrombocytopenia, historical and forecasted epidemiology as well as the Chemotherapy-induced Thrombocytopenia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Chemotherapy-induced Thrombocytopenia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chemotherapy-induced Thrombocytopenia Market Forecast https://www.delveinsight.com/sample-request/chemotherapy-induced-thrombocytopenia-cit-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key

All 5 Releases


More Releases for Von

"Die Bedeutung von Instagram für den Kunstmarkt - Eine Perspektive von Andrew C …
Die Kunstbranche hat in den letzten Jahren einen bedeutenden Wandel erfahren, wobei Social-Media-Plattformen wie Instagram eine entscheidende Rolle bei der Vernetzung von Künstlern, Galerien und Sammlern auf der ganzen Welt spielen. Andrew Jovic, auch bekannt als Andrew Cyberkid (www.andrewcyberkid.com), ist ein herausragendes Beispiel für die Kraft der sozialen Medien in der Kunstwelt. Sein Instagram-Account (@cyberkid70) ist ein Anziehungspunkt für Urban- und Street-Art-Enthusiasten und bietet Künstlern und Sammlern eine Plattform, um
05-11-2021 | Health & Medicine
Fact.MR
Von Willebrand disease treatment therapies and Von Willebrand Disease treatment …
The research report presents a comprehensive assessment of the Von Willebrand Disease Treatment Market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application and industry To remain ‘ahead’ of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=1496 Von Willebrand Disease
Ein Hauch von China in Berlin Mitte
Startup-Business von Peking nach Berlin Es ist Freitagabend, 19 Uhr in Peking. Genauer: in Zhongguancun, dem High-Tech-Mekka Asiens. Auch die fleißigsten Unternehmer im Silicon Valley Chinas, wie das Viertel im Pekinger Stadtteil Haidian oft genannt wird, freuen sich auf das bevorstehende Wochenende und auf ein wenig Abstand von der Arbeit. Zumindest auf den räumlichen Switch in die eigenen vier Wände und das heimische Sofa. Auch die junge Chinesin und Techcode-Mitarbeiterin Li Na
05-10-2016 | Health & Medicine
Kerecis
Die Anwendung von Fischhaut beschleunigt die Heilung von offenen, schwer heilbar …
„High-Impact“-Studien, die Kerecis auf einer großen europäischen Wundkonferenz präsentiert, zeigen beschleunigte und verbesserte Heilung der Wunden Bremen, 09. Mai 2016 – Kerecis, das Unternehmen, das mit Omega-3-reicher Fischhaut menschliche Wunden und Gewebeschäden heilt, präsentiert vom 11. bis 13. Mai auf dem European Wound Management Symposium (EWMA) in Bremen Ergebnisse von in vivo und in vitro durchgeführten Versuchen. Der Austellungsplatz von Kerecis findet sich am Stand 1A 05. In einer Studie führte die
FRIEDERIKE VON RAUCH | IN SECRET
Friederike von Rauch’s exhibition In Secret presents a selection of her photographs from different series produced between 2010 and 2013: focused and picturesque compositions of light and shade that elevate unremarkable architectural details to the status of stand-alone subjects and question our habits of perception. The works were created in various European museums and post-war modernist churches. Following her training as a silversmith, Friederike von Rauch studied Industrial Design at
Koreans love "Princess Maja von Hohenzollern" - designs
Baby- bath- line "STyLE! Princess" designed by Princess Maja von Hohenzollern on the road to succcess in Korea. The charming baby bath line "STyLE! Princess" in delicate pink and elegant silver-gray, has been designed by Princess Maja Princess of Hohenzollern for little princes & princesses. The cute baby bath line is also among the Koreans in great favor. The "Guhee Corporation" is selling the "Princess Style-Line" at consumer fairs and throughout